Leukoreduced buffy coat–derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Transfusion

• Publication date

  2007-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1537-2995.2007.01169.xPMID 17381625
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet ADP response deteriorates in synthetic storage media

  2006cited by this paper
• Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia

  2006cited by this paper
• Transfusion of 7‐day‐old amotosalen photochemically treated buffy‐coat platelets to patients with thrombocytopenia: a pilot study

  2006cited by this paper
• Bacterial detection and extended platelet storage: The next step forward

  2005cited by this paper
• Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004

  2005cited by this paper
• In vitro and in vivo evaluation of leukoreduced platelets stored for 7 days in CLX containers

  2005cited by this paper
• In vitro evaluation of prestorage pooled leukoreduced whole blood–derived platelets stored for up to 7 days

  2005cited by this paper
• Bacterial detection of platelets: current problems and possible resolutions.

  2005cited by this paper
• Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set

  2005cited by this paper
• Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long‐wavelength ultraviolet irradiation

  2005cited by this paper
• Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long‐wavelength ultraviolet light

  2005cited by this paper
• Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.

  2004cited by this paper
• Photochemical treatment of platelet concentrates with amotosalen and long‐wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria

  2004cited by this paper
• Storage of platelets in additive solution for up to 12 days with maintenance of good in‐vitro quality

  2004cited by this paper
• Recovery and life span of 111indium‐radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S‐59) and ultraviolet A light

  2004cited by this paper
• Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial.

  2003cited by this paper
• The clearance mechanism of chilled blood platelets.

  2003cited by this paper
• Trypanosoma cruzi Inactivation in Human Platelet Concentrates and Plasma by a Psoralen (Amotosalen HCl) and Long-Wavelength UV

  2003cited by this paper
• Seven‐day storage of single‐donor platelets: recovery and survival in an autologous transfusion study

  2002cited by this paper
• What's so bad about old platelets?

  2002cited by this paper
• Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage

  1999cited by this paper
• Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA.

  1998cited by this paper
• Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long‐wavelength ultraviolet light

  1997cited by this paper
• Procoagulant Effect of Incompatible Platelet Transfusions in Alloimmunized Refractory Patients

  1996cited by this paper
• Platelet concentrates promote procoagulant activity: evidence from experimental studies using a perfusion technique

  1995cited by this paper
• The role of the Baumgartner technique in transfusion medicine: research and clinical applications

  1994cited by this paper
• Experimental basis for the use of red cell transfusion in the management of anemic‐thrombocytopenic patients

  1988cited by this paper
• Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination.

  1985cited by this paper
• Factor VIII-von Willebrand factor requires calcium for facilitation of platelet adherence.

  1984cited by this paper
• Factor VIII-von Willebrand factor requires calcium for facilitation of platelet adherence

  1984cited by this paper
• The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi.

  1973cited by this paper
• Effect of storage temperature on maintenance of platelet viability--deleterious effect of refrigerated storage.

  1969cited by this paper

• Pathogen reduction diminishes the protective effects of platelets on endothelial barrier permeability in vitro

  2025cites this paper
• Optimized pathogen reduction of double‐dose platelets pooled from seven buffy coats using the TACSI® system

  2025cites this paper
• Biochemical and functional characteristics of stored (double‐dose) buffy‐coat platelet concentrates treated with amotosalen and a prototype UVA light‐emitting diode illuminator

  2023cites this paper
• Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review

  2022cites this paper
• Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic

  2021cites this paper
• Pathogen reduction of platelets: experience of a single blood bank

  2021cites this paper
• Alternative methods of platelet storage and pathogen reduction

  2021cites this paper
• In vitro thrombus formation and in vivo hemostasis mediated by platelets irradiated with bactericidal ultraviolet C from xenon flash under flow conditions

  2020cites this paper
• The long and winding road to pathogen reduction of platelets, red blood cells and whole blood

  2019cites this paper
• General overview of blood products in vitro quality: Processing and storage lesions.

  2018cites this paper
• Ultraviolet-Based Pathogen Inactivation Systems: Untangling the Molecular Targets Activated in Platelets

  2018cites this paper
• Pathogen-Inaktivierungssysteme für Thrombozytenkonzentrate

  2018cites this paper
• Amotosalen/UVA pathogen inactivation technology reduces platelet activability, induces apoptosis and accelerates clearance

  2017cites this paper
• Platelet concentrates: Balancing between efficacy and safety?

  2016cites this paper
• In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB‐treated platelet concentrates

  2015cites this paper
• In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step.

  2015cites this paper
• The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.

  2014cites this paper
• Current methods for the reduction of blood-borne pathogens: a comprehensive literature review.

  2013cites this paper
• In vitro assessment of buffy‐coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system

  2013cites this paper
• Analysis of reasons for not implementing pathogen inactivation for platelet concentrates.

  2013cites this paper
• Pathogen Reduction Technologies: The Best Solution for Safer Blood?

  2013cites this paper
• Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation

  2013cites this paper
• Proteomic analysis of Intercept-treated platelets.

  2012cites this paper
• Meta‐analysis of the studies of bleeding complications of platelets pathogen‐reduced with the Intercept system

  2012cites this paper
• Therapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta‐analysis of randomized controlled trials

  2012cites this paper
• Glucose in platelet additive solutions: to add or not to add?

  2011cites this paper
• Réduction de pathogènes des concentrés de plaquettes : techniques existantes et en développement

  2011cites this paper
• Methods for testing platelet function for transfusion medicine

  2011cites this paper
• A multi‐centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion

  2011cites this paper
• [Pathogen reduction for platelets: available techniques and recent developments].

  2011cites this paper
• Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTM

  2011cites this paper
• Meta‐analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen‐reduced platelets

  2011cites this paper
• Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function

  2011cites this paper
• The effectiveness and economics of bacteriological control of blood components

  2010cites this paper
• Application of the bactericidal activity of ε‐poly‐l‐lysine to the storage of human platelet concentrates

  2010cites this paper
• Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction

  2010cites this paper
• Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality.

  2010cites this paper
• Platelet function assessed by shear‐induced deposition of split triple‐dose apheresis concentrates treated with pathogen reduction technologies

  2009cites this paper
• Application of proteomics to the study of protein translation in stored platelet units

  2008cites this paper
• Platelet storage lesion: a new understanding from a proteomic perspective.

  2008cites this paper
• The residual risk of sepsis: modeling the effect of concentration on bacterial detection in two‐bottle culture systems and an estimation of false‐negative culture rates

  2007cites this paper